In summary, while GLP1-RA has demonstrated beneficial effects on kidney outcomes in patients with T2D, further studies are needed to fully elucidate their impact on severe kidney outcomes such as eGFR decline, progression to ESKD, and kidney-related death. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.